ADMA
ADMA Biologics, Inc. · Healthcare · Biotechnology
Momentum inputs (comparable managers): holder breadth 0.0% · share flow -14.3% · net new positions 0.0% — formula
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q1 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 107 | -1 | 146.21M | $1.22B | +9 | −10 |
| Q1 2026 | 111 | -5 | 163.83M | $1.48B | +7 | −12 |
| Q4 2025 | 115 | +1 | 163.64M | $2.98B | +1 | — |
| Q3 2025 | 19 | +1 | 92.34M | $1.35B | +3 | −3 |
| Q2 2025 | 16 | -1 | 89.41M | $1.63B | +1 | −2 |
| Q1 2025 | 14 | 0 | 31.71M | $629.12M | — | — |
| Q4 2024 | 14 | +2 | 37.00M | $634.64M | +2 | — |
| Q3 2024 | 11 | -2 | 23.86M | $476.89M | — | −2 |
| Q2 2024 | 13 | — | 23.97M | $268.00M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (passive) | 11.44M | -23.1% | $226.99M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 5.67M | +4.3% | $112.47M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 3 | Geode Capital Management ✦ (passive) | 5.67M | +4.3% | $112.47M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 4 | Renaissance Technologies ✦ | 3.55M | -5.9% | $70.41M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 5 | Two Sigma Investments ✦ | 2.26M | -11.5% | $44.75M | 0.1% | ▼ Trim | 4 | SEC ↗ |
| 6 | Millennium Management ✦ | 2.15M | +85.1% | $42.58M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 7 | T. Rowe Price ✦ | 2.11M | +0.5% | $41.88M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 8 | T. Rowe Price ✦ | 2.11M | +0.5% | $41.88M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 9 | D. E. Shaw & Co. ✦ | 1.53M | -50.2% | $30.27M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 10 | Arrowstreet Capital ✦ | 1.12M | -59.6% | $22.14M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 11 | Point72 Asset Management ✦ | 847.56K | +299.2% | $16.82M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 519.89K | -1.9% | $10.31M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 519.89K | -1.9% | $10.31M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 519.89K | -1.9% | $10.31M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 519.89K | -1.9% | $10.31M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 519.89K | -1.9% | $10.31M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 17 | Citadel Advisors ✦ | 241.21K | +52.2% | $4.79M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 18 | Citadel Advisors ✦ | 241.21K | +52.2% | $4.79M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 19 | Gotham Asset Management ✦ | 164.25K | -1.5% | $3.26M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 20 | Wellington Management ✦ | 93.82K | -11.0% | $1.86M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 21 | Wellington Management ✦ | 93.82K | -11.0% | $1.86M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 22 | Wellington Management ✦ | 93.82K | -11.0% | $1.86M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 23 | Wellington Management ✦ | 93.82K | -11.0% | $1.86M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 24 | Norges Bank ✦ (passive) | 30.13K | -74.8% | $597,839 | 0.0% | ▼ Trim | 2 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 355 holders, 211.31M shares, $1.84B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.